These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37726373)

  • 21. Effect of fish oil supplementation on the concentration of miRNA-122, FGF-21 and liver fibrosis in patients with NAFLD: Study protocol for a randomized, double-blind and placebo-controlled clinical trial.
    Barroso LN; Salarini J; Leite NC; Villela-Nogueira CA; Dávalos A; Carmo MDGT; Ferreira Peres WA
    Clin Nutr ESPEN; 2023 Oct; 57():117-125. PubMed ID: 37739645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simple Resistance Exercise helps Patients with Non-alcoholic Fatty Liver Disease.
    Takahashi A; Abe K; Usami K; Imaizumi H; Hayashi M; Okai K; Kanno Y; Tanji N; Watanabe H; Ohira H
    Int J Sports Med; 2015 Oct; 36(10):848-52. PubMed ID: 26090879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates.
    Garteiser P; Castera L; Coupaye M; Doblas S; Calabrese D; Dioguardi Burgio M; Ledoux S; Bedossa P; Esposito-Farèse M; Msika S; Van Beers BE; Jouët P
    JHEP Rep; 2021 Dec; 3(6):100381. PubMed ID: 34786549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alterations of liver enzymes and lipid profile in response to exhaustive eccentric exercise: vitamin D supplementation trial in overweight females with non-alcoholic fatty liver disease.
    Rahimpour Z; Hoseini R; Behpour N
    BMC Gastroenterol; 2022 Aug; 22(1):372. PubMed ID: 35927637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of a fruit-rich diet on liver biomarkers, insulin resistance, and lipid profile in patients with non-alcoholic fatty liver disease: a randomized clinical trial.
    Alami F; Alizadeh M; Shateri K
    Scand J Gastroenterol; 2022 Oct; 57(10):1238-1249. PubMed ID: 35710164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum procalcitonin and CRP levels in non-alcoholic fatty liver disease: a case control study.
    Oruc N; Ozutemiz O; Yuce G; Akarca US; Ersoz G; Gunsar F; Batur Y
    BMC Gastroenterol; 2009 Feb; 9():16. PubMed ID: 19222849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of combined exercises on the plasma levels of retinol-binding protein 4 and its relationship with insulin resistance and hepatic fat content in postmenopausal women with nonalcoholic fatty liver disease.
    Norouzpour M; Marandi SM; Ghanbarzadeh M; Zare Maivan A
    J Sports Med Phys Fitness; 2022 May; 62(5):684-690. PubMed ID: 33871240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus.
    Lee H; Kim G; Choi YJ; Huh BW; Lee BW; Kang ES; Cha BS; Lee EJ; Lee YH; Huh KB
    Diabetes Metab J; 2020 Apr; 44(2):267-276. PubMed ID: 30877708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C-reactive protein in Hispanics.
    Riquelme A; Arrese M; Soza A; Morales A; Baudrand R; Pérez-Ayuso RM; González R; Alvarez M; Hernández V; García-Zattera MJ; Otarola F; Medina B; Rigotti A; Miquel JF; Marshall G; Nervi F
    Liver Int; 2009 Jan; 29(1):82-8. PubMed ID: 18647235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modified high-intensity interval training reduces liver fat and improves cardiac function in non-alcoholic fatty liver disease: a randomized controlled trial.
    Hallsworth K; Thoma C; Hollingsworth KG; Cassidy S; Anstee QM; Day CP; Trenell MI
    Clin Sci (Lond); 2015 Dec; 129(12):1097-105. PubMed ID: 26265792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of a moderately carbohydrate-restricted diet on liver enzymes, steatosis and fibrosis in normal-weight individuals with non-alcoholic fatty liver disease: study protocol for a parallel randomised controlled clinical trial.
    Dashti F; Alavian SM; Sohrabpour AA; Mousavi SE; Keshavarz SA; Esmaillzadeh A
    BMJ Open; 2023 Apr; 13(4):e063988. PubMed ID: 37117000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Relationship between Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease Measured by Controlled Attenuation Parameter.
    Chon YE; Kim KJ; Jung KS; Kim SU; Park JY; Kim do Y; Ahn SH; Chon CY; Chung JB; Park KH; Bae JC; Han KH
    Yonsei Med J; 2016 Jul; 57(4):885-92. PubMed ID: 27189281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucose homeostasis, insulin resistance and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Beneficial effects of supplementation with microalgae Chlorella vulgaris: A double-blind placebo-controlled randomized clinical trial.
    Ebrahimi-Mameghani M; Sadeghi Z; Abbasalizad Farhangi M; Vaghef-Mehrabany E; Aliashrafi S
    Clin Nutr; 2017 Aug; 36(4):1001-1006. PubMed ID: 27475283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease.
    de Lédinghen V; Wong GL; Vergniol J; Chan HL; Hiriart JB; Chan AW; Chermak F; Choi PC; Foucher J; Chan CK; Merrouche W; Chim AM; Le Bail B; Wong VW
    J Gastroenterol Hepatol; 2016 Apr; 31(4):848-55. PubMed ID: 26514665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulmonary function test abnormalities in children and adolescents with non-alcoholic fatty liver disease.
    El Amrousy D; El Ashry H; Maher S; Ganna S; Hasan S
    Eur J Pediatr; 2021 Jun; 180(6):1693-1699. PubMed ID: 33479799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myosteatosis in nonalcoholic fatty liver disease: An exploratory study.
    De Munck TJI; Verhaegh P; Lodewick T; Bakers F; Jonkers D; Masclee AAM; Verbeek J; Koek GH
    Clin Res Hepatol Gastroenterol; 2021 May; 45(3):101500. PubMed ID: 32828745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of hepatic steatosis on native T1 mapping of 3T magnetic resonance imaging in the assessment of T1 values for patients with non-alcoholic fatty liver disease.
    Ahn JH; Yu JS; Park KS; Kang SH; Huh JH; Chang JS; Lee JH; Kim MY; Nickel MD; Kannengiesser S; Kim JY; Koh SB
    Magn Reson Imaging; 2021 Jul; 80():1-8. PubMed ID: 33798658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients.
    Darweesh SK; AbdElAziz RA; Abd-ElFatah DS; AbdElazim NA; Fathi SA; Attia D; AbdAllah M
    Eur J Gastroenterol Hepatol; 2019 May; 31(5):633-641. PubMed ID: 30839434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of daily consumption of probiotic yogurt on liver enzymes, steatosis and fibrosis in patients with nonalcoholic fatty liver disease (NAFLD): study protocol for a randomized clinical trial.
    Ebrahimi-Mousavi S; Alavian SM; Sohrabpour AA; Dashti F; Djafarian K; Esmaillzadeh A
    BMC Gastroenterol; 2022 Mar; 22(1):102. PubMed ID: 35255811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-alcoholic fatty liver disease is closely associated with sub-clinical inflammation: a case-control study on Asian Indians in North India.
    Nigam P; Bhatt SP; Misra A; Vaidya M; Dasgupta J; Chadha DS
    PLoS One; 2013; 8(1):e49286. PubMed ID: 23326306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.